Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 52.40
+4.40 (9.17%)
Mar 6, 2026, 4:08 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 15.44 billion as of March 6, 2026. Its market cap has increased by 69.73% in one year.
Market Cap
15.44B
Enterprise Value
13.33B
Revenue
955.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
52.40
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has decreased from 18.43B to 15.44B, a decrease of -16.23%. That is a compound annual growth rate of -3.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 15.44B | -1.96% |
| Dec 31, 2025 | 15.75B | 84.90% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
| Jul 8, 2021 | 18.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PegBio | 23.43B |
| InnoCare Pharma | 22.09B |
| Zai Lab | 16.88B |
| Ascentage Pharma Group International | 15.27B |
| Ascletis Pharma | 15.07B |
| Everest Medicines | 12.04B |
| Guangzhou Innogen Pharmaceutical Group | 10.18B |
| Nanjing Leads Biolabs | 9.95B |